Aglaia Oncology Funds Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
3
- Investments
-
19
- Portfolio
-
5
- Exits
-
7
Aglaia Oncology Funds General Information
Company Description
Founded in 2004, Aglaia Oncology Funds is a venture capital firm based in Bilthoven, Netherlands. The firm invests in early-stage oncology drug development-focused companies.
Business Details
Investor Status
Primary Investor Type
Corporate Office
- Businesspark Berg en Bosch
- Professor Bronkhorstlaan 10, Building 92
- 3723 MB Bilthoven
- Netherlands
Aglaia Oncology Funds Investments (19)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| InteRNA Technologies | 09-Feb-2021 | Later Stage VC | Drug Discovery | Bankruptcy: Liquidation | ||
| Sapreme Technologies | 07-Oct-2020 | Drug Discovery | Generating Revenue | |||
| Inthera Bioscience | 26-Jun-2018 | Drug Discovery | Pre-Clinical Trials | |||
| MIMETAS | 11-Apr-2018 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Macrophage Pharma | 23-Aug-2017 | Drug Discovery | Bankruptcy: Liquidation | |||
| Cristal Therapeutics | 19-Jan-2017 | Drug Discovery | Generating Revenue | |||
| Sapreme Technologies | 01-Jan-2017 | Drug Discovery | Generating Revenue | |||
| Modra Pharmaceuticals | 01-Apr-2016 | Drug Discovery | Generating Revenue | |||
| Inthera Bioscience | 14-Dec-2015 | Seed Round | Drug Discovery | Pre-Clinical Trials | ||
| InteRNA Technologies | 29-Oct-2015 | Later Stage VC | Drug Discovery | Bankruptcy: Liquidation |
Aglaia Oncology Funds Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Macrophage Pharma | 05-Dec-2023 | Bankruptcy: Liquidation | |
| InteRNA Technologies | 27-Mar-2023 | ||
| Merus | 19-May-2016 | ||
| Syntarga | 23-Jun-2011 | ||
| ISA Pharmaceuticals | |||
| ORCA Therapeutics | Secondary Transaction - Private | ||
| SomantiX | Out of Business |
Aglaia Oncology Funds Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Aglaia Oncology Funds Co-Investors (6)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Alumni Ventures | 1 |
|
|
||
| AurorA Science |
|
|
|||
| BioX Biosciences |
|
|
|||
| Inkef |
|
|
|||
| Oost NL |
|
|
Aglaia Oncology Funds FAQs
-
What is Aglaia Oncology Funds?
Founded in 2004, Aglaia Oncology Funds is a venture capital firm based in Bilthoven, Netherlands.
-
When was Aglaia Oncology Funds founded?
Aglaia Oncology Funds was founded in 2004.
-
Where is Aglaia Oncology Funds headquartered?
Aglaia Oncology Funds is headquartered in Bilthoven, Netherlands.
-
How many investments has Aglaia Oncology Funds made?
Aglaia Oncology Funds has made 19 investments.
-
What has Aglaia Oncology Funds invested in?
Aglaia Oncology Funds has made numerous investments in companies like InteRNA Technologies, Sapreme Technologies, and Inthera Bioscience within the Drug Discovery industry.
-
What has Aglaia Oncology Funds invested in recently?
Aglaia Oncology Funds's latest investment was on 09-Feb-2021 in InteRNA Technologies, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
